Cott (TSE:PRM – Get Free Report) was upgraded by analysts at BMO Capital Markets to a “strong-buy” rating in a research report issued on Monday,Zacks.com reports.
Several other research firms have also recently issued reports on PRM. Raymond James cut shares of Cott from a “moderate buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. William Blair upgraded Cott to a “strong-buy” rating in a research report on Thursday, October 24th.
View Our Latest Report on Cott
Cott Stock Up 0.3 %
Cott Company Profile
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Read More
- Five stocks we like better than Cott
- Compound Interest and Why It Matters When Investing
- These 3 Airline Stocks Have Analysts Feeling Bullish for 2025
- About the Markup Calculator
- Is Raytheon the Best Defense and Aerospace Stock to Own in 2025?
- How to Invest in the FAANG Stocks
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
Receive News & Ratings for Cott Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cott and related companies with MarketBeat.com's FREE daily email newsletter.
